Nunzia Pharmaceutical Company
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.

Profit Margin

Nunzia Pharmaceutical Company (OTC:NUNZ): Profit margin
2017 0 -13.04K
2018 0 -18.57K
2019 0 -33.63K
2020 0 -9.01M
2021 0 -78.06M
2022 0 0

NUNZ Income Statement (2017 – 2022)

2022 2021 2020 2019 2018 2017
Revenue
Revenue
000000
Cost of revenue
000000
Gross profit
000000
Operating exp.
Research and development
000000
Selling and marketing
000000
Total operating expenses
078.06M16.32K33.63K27.17K13.04K
Operating income
0-78.06M-16.32K-33.63K-27.17K-13.04K
Other income (expenses), net
0-1.86K-8.97M58.59K0
Income before tax
0-78.06M-9.01M-33.63K-18.57K-13.04K
Income tax expense
01.86K0-28-8.59K0
Net income
0-78.06M-9.01M-33.63K-18.57K-13.04K
Earnings per share
Basic EPS
0-0.26-0.03-0.00-0.00-0.00
Diluted EPS
0-0.26-0.03-0.00-0.00-0.00
Data sourceData sourceData source